548
Views
11
CrossRef citations to date
0
Altmetric
Review

Female pattern alopecia: current perspectives

&
Pages 541-556 | Published online: 29 Aug 2013

References

  • OlsenEAReedKBCacchioPBCaudillLIron deficiency in female pattern hair loss, chronic telogen effluvium, and control groupsJ Am Acad Dermatol201063699199920947203
  • NorwoodOTIncidence of female androgenetic alopecia (female pattern alopecia)Dermatol Surg2001271535411231244
  • BirchMPMessengerJFMessengerAGHair density, hair diameter and the prevalence of female pattern hair lossBr J Dermatol2001144229730411251562
  • GonzalezMECantatore-FrancisJOrlowSJAndrogenetic alopecia in the paediatric population: a retrospective review of 57 patientsBr J Dermatol2010163237838520346026
  • CashTFPriceVHSavinRCPsychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjectsJ Am Acad Dermatol19932945685758408792
  • CamachoFMGarcía-HernándezMPsychological features of androgenetic alopeciaJ Eur Acad Dermatol Venereol200216547648012428841
  • LeskoSMRosenbergLShapiroSA case-control study of baldness in relation to myocardial infarction in menJAMA1993269899810038429606
  • ShaharEHeissGRosamondWDSzkloMBaldness and myocardial infarction in men: the atherosclerosis risk in communities studyAm J Epidemiol2008167667668318208984
  • OhBRKimSJMoonJDAssociation of benign prostatic hyperplasia with male pattern baldnessUrology19985157447489610587
  • FaydaciGBilalENecmettinPFatihTAsumanOUğurKBaldness, benign prostate hyperplasia, prostate cancer and androgen levelsAging Male200811418919219172550
  • LudwigEClassification of the types of androgenetic alopecia (common baldness) occurring in the female sexBr J Dermatol1977973247254921894
  • OlsenEAHordinskyMRobertsJLWhitingDADermatologic Consortium for Women’s HealthFemale pattern hair lossJ Am Acad Dermatol200247579512399780
  • OlsenEACurrent and novel methods for assessing efficacy of hair growth promoters in pattern hair lossJ Am Acad Dermatol200348225326212582397
  • BirchMPLallaSCMessengerAGFemale pattern hair lossClin Exp Dermatol200227538338812190638
  • SinclairRDDawberRPAndrogenetic alopecia in men and womenClin Dermatol200119216717811397596
  • WhitingDAWaldstreicherJSanchezMKaufmanKDMeasuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal womenJ Investig Dermatol Symp Proc199943282284
  • MessengerAGSinclairRFollicular miniaturization in female pattern hair loss: clinicopathological correlationsBr J Dermatol2006155592693017034520
  • RandallVAAndrogens and hair growthDermatol Ther200821531432818844710
  • PriceVHAndrogenetic alopecia in womenJ Investig Dermatol Symp Proc2003812427
  • FutterweitWDunaifAYe hHCKingsleyPThe prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopeciaJ Am Acad Dermatol1988195 Pt 18318363192772
  • SawayaMEPriceVHDifferent levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopeciaJ Invest Dermatol199710932963009284093
  • OrmeSCullenDRMessengerAGDiffuse female hair loss: are androgens necessary?Br J Dermatol1999141352152310583059
  • YipLRufautNSinclairRRole of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: an update of what we now knowAustralas J Dermatol2011522818821605090
  • ConradFPausREstrogens and the hair follicleJ Dtsch Dermatol Ges20042641242316281598
  • YipLZaloumisSIrwinDGene-wide association study between the aromatase gene (CYP19A1) and female pattern hair lossBr J Dermatol2009161228929419438456
  • ZappacostaARReversal of baldness in patient receiving minoxidil for hypertensionN Engl J Med198030325148014817432414
  • MessengerAGRundegrenJMinoxidil: mechanisms of action on hair growthBr J Dermatol2004150218619414996087
  • PriceVHTreatment of hair lossN Engl J Med19993411396497310498493
  • HaberRSPharmacologic management of pattern hair lossFacial Plast Surg Clin North Am200412218118915135128
  • WhitingDAJacobsonCTreatment of female androgenetic alopecia with minoxidil 2%Int J Dermatol199231118008041428436
  • JacobsJPSzpunarCAWarnerMLUse of topical minoxidil therapy for androgenetic alopecia in womenInt J Dermatol199332107587628225725
  • LuckyAWPiacquadioDJDitreCMA randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair lossJ Am Acad Dermatol200450454155315034503
  • Blume-PeytaviUHillmannKDietzECanfieldDGarcia BartelsNA randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in womenJ Am Acad Dermatol201165611261134 e221700360
  • van ZuurenEJFedorowiczZCarterBAndrioloRBSchoonesJInterventions for female pattern hair lossCochrane Database Syst Rev20125CD00762822592723
  • PriceVHMenefeeEStraussPCChanges in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatmentJ Am Acad Dermatol1999415 Pt 171772110534633
  • Johnson and Johnson Consumer and Personal Products WorldwideA phase 3 multi-center parallel design clinical trial to compare the efficacy and safety of 5% minoxidil foam vs 2% minoxidil solution in females for the treatment of female pattern hair loss – androgenetic alopecia Available from http://clinicaltrials.gov/show/NCT01145625. NLM identifier: NCT01145625Accessed April 10, 2013
  • ThuangtongRPilot study of the efficacy in treatment of female pattern hair loss using 5% minoxidil solution combined with oral chelated zinc supplement Available from: http://clinicaltrials.gov/ct2/show/NCT01662089. NLM identifier: NCT01662089Accessed April 10, 2013
  • RafiAWKatzRMPilot study of 15 patients receiving a new treatment regimen for androgenic alopecia: the effects of atopy on AGAISRN Dermatol2011201124195322363845
  • HoedemakerCvan EgmondSSinclairRTreatment of female pattern hair loss with a combination of spironolactone and minoxidilAustralas J Dermatol2007481434517222303
  • GelfusoGMGratieriTDelgado-CharroMBGuyRHVianna LopezRFIontophoresis-targeted, follicular delivery of minoxidil sulfate for the treatment of alopeciaJ Pharm Sci201310251488149423450524
  • van den HurkCJvan den Akker-van MarleMEBreedWPvan de Poll-FranseLVNortierJWCoeberghJWImpact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancerEur J Oncol Nurs Epub462013
  • GormleyGJFinasteride: a clinical reviewBiomed Pharmacother1995497–83193248562856
  • Propecia [package insert]White House Station, NJMerck and Co, Inc102004
  • Proscar [package insert]White House Station, NJMerck and Co, Inc12013
  • KaufmanKDOlsenEAWhitingDFinasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study GroupJ Am Acad Dermatol1998394 Pt 15785899777765
  • LeydenJDunlapFMillerBFinasteride in the treatment of men with frontal male pattern hair lossJ Am Acad Dermatol1999406 Pt 193093710365924
  • PriceVHRobertsJLHordinskyMLack of efficacy of finasteride in postmenopausal women with androgenetic alopeciaJ Am Acad Dermatol2000435 Pt 176877611050579
  • YeonJHJungJYChoiJW5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair lossJ Eur Acad Dermatol Venereol201125221121420569283
  • TrüebRMSwiss Trichology Study GroupFinasteride treatment of patterned hair loss in normoandrogenic postmenopausal womenDermatolog y20042093202207
  • BoychenkoOBernsteinRMSchweigerESFinasteride in the treatment of female pattern (androgenic) alopecia: a case report and review of the literatureCutis2012902737622988650
  • ThaiKESinclairRDFinasteride for female androgenetic alopeciaBr J Dermatol2002147481281312366441
  • ValsecchiRLeghissaPRivaMFemale androgenetic alopecia treated by finasteride: a case forwardActa Derm Venereol200484648848915844649
  • ShumKWCullenDRMessengerAGHair loss in women with hyperandrogenism: four cases responding to finasterideJ Am Acad Dermatol200247573373912399766
  • CarminaELoboRATreatment of hyperandrogenic alopecia in womenFertil Steril2003791919512524069
  • Avodart [package insert]Research Triangle Park, NCGlaxoSmithKline102012
  • EunHCKwonOSYeonJHEfficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III studyJ Am Acad Dermatol201063225225820605255
  • StoughDDutasteride improves male pattern hair loss in a randomized study in identical twinsJ Cosmet Dermatol20076191317348989
  • OlsenEAHordinskyMWhitingDDutasteride Alopecia Research TeamThe importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasterideJ Am Acad Dermatol20065561014102317110217
  • BoyapatiASinclairRCombination therapy with finasteride and low-dose dutasteride in the treatment of androgenetic alopeciaAustralas J Dermatol2013541495122686691
  • OlszewskaMRudnickaLEffective treatment of female androgenic alopecia with dutasterideJ Drug Dermatol200545637640
  • MoftahNMoftahNAbd-ElazizGMesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluationJ Eur Acad Dermatol Venereol201327668669322486925
  • SharmaPJainDMaithaniMDevelopment and characterization of dutasteride bearing liposomal systems for topical useCurr Drug Discov Technol20118213614521513483
  • RathnayakeDSinclairRInnovative use of spironolactone as an anti-androgen in the treatment of female pattern hair lossDermatol Clin201028361161820510769
  • Aldactone [package insert]New York, NYPfizer Inc102012
  • RathnayakeDSinclairRUse of spironolactone in dermatologySkinmed20108632833221413648
  • KatsambasADDessiniotiCHormonal therapy for acne: why not as first line therapy? Facts and controversiesClin Dermatol2010281172320082945
  • GómezRNúñezLCaballeroRVaqueroMTamargoJDelpónESpironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1 + mink channelsBr J Pharmacol2005146114616115980874
  • YazdabadiAGreenJSinclairRSuccessful treatment of female-pattern hair loss with spironolactone in a 9-year-old girlAustralas J Dermatol200950211311419397563
  • AdamopoulosDAKaramertzanisMNicopoulouSGregoriouABeneficial effect of spironolactone on androgenic alopeciaClin Endocrinol (Oxf)19974767597609497885
  • BurkeBMCunliffeWJOral spironolactone therapy for female patients with acne, hirsutism or androgenic alopeciaBr J Dermatol198511211241253155956
  • SinclairRWewerinkeMJolleyDTreatment of female pattern hair loss with oral antiandrogensBr J Dermatol2005152346647315787815
  • LumachiFRondinoneRUse of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutismFertil Steril200379494294612749435
  • ThaiKESinclairRDSpironolactone-induced hepatitisAustralas J Dermatol200142318018211488711
  • HughesBRCunliffeWJTolerance of spironolactoneBr J Dermatol198811856876912969259
  • Brzezińska-WcisłoL[Assessment of efficacy of Diane-35 in androgenetic feminine alopecia.]Wiad Lek2003563–4202205 Polish12923971
  • DinhQQSinclairRFemale pattern hair loss: current treatment conceptsClin Interv Aging20072218919918044135
  • RushtonDHRamsayIDThe importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in womenClin Endocrinol (Oxf)19923644214271424176
  • Karrer-VoegeliSReyFReymondMJMeuwlyJYGaillardRCGomezFAndrogen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenismMedicine (Baltimore)2009881324519352298
  • VexiauPChaspouxCBoudouPEffects of minoxidil 2% vs cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trialBr J Dermatol2002146699299912072067
  • ScheinfeldNA review of hormonal therapy for female pattern (androgenic) alopeciaDermatol Online J2008143118627703
  • SimardJLuthyIGuayJBélangerALabrieFCharacteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissuesMol Cell Endocrinol19864432612703956856
  • ParadisiRPorcuEFabbriRSeracchioliRBattagliaCVenturoliSProspective cohort study on the effects and tolerability of flutamide in patients with female pattern hair lossAnn Pharmacother201145446947521487083
  • YazdabadiASinclairRTreatment of female pattern hair loss with the androgen receptor antagonist flutamideAustralas J Dermatol201152213213421605098
  • Xalatan [package insert]New York, NYPfizer Inc82011
  • Travatan [package insert]Fort Worth, TXAlcon Laboratories Inc92011
  • Lumigan [package insert]Irivine, CAAllergan Inc2012
  • Latisse [package insert]Irivine, CAAllergan Inc2012
  • MassakiABFabiSGFitzpatrickRRepigmentation of hypopigmented scars using an erbium-doped 1,550-nm fractionated laser and topical bimatoprostDermatol Surg2012387 Pt 1995100122540767
  • CohenJLEnhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growthDermatol Surg20103691361137120384750
  • JohnstoneMAAlbertDMProstaglandin-induced hair growthSurv Ophthalmol200247Suppl 1S185S20212204716
  • UnoHZimbricMLAlbertDMStjernschantzJEffect of latanoprost on hair growth in the bald scalp of the stump-tailed macacque: a pilot studyActa Derm Venereol200282171212013211
  • Blume-PeytaviULönnforsSHillmannKGarcia BartelsNA randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopeciaJ Am Acad Dermatol201266579480021875758
  • EmerJJStevensonMLMarkowitzONovel treatment of female-pattern androgenetic alopecia with injected bimatoprost 0.03% solutionJ Drugs Dermatol201110779579821720663
  • AllerganSafety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss Available from http://clinicaltrials.gov/ct2/show/NCT01325350. NLM identifier: NCT01325350Accessed April 9, 2013
  • FaghihiGAndalibFAsilianAThe efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrowsEur J Dermatol200919658658719620039
  • Coronel-PérezIMRodríguez-ReyEMCamacho-MartínezFMLatanoprost in the treatment of eyelash alopecia in alopecia areata universalisJ Eur Acad Dermatol Venereol201024448148520028444
  • Piérard-FranchimontCDe DonckerPCauwenberghGPiérardGEKetoconazole shampoo: effect of long-term use in androgenic alopeciaDermatolog y19981964474477
  • KhandpurSSumanMReddyBSComparative efficacy of various treatment regimens for androgenetic alopecia in menJ Dermatol200229848949812227482
  • JiangJTsuboiRKojimaYOgawaHTopical application of ketoconazole stimulates hair growth in C3H/HeN miceJ Dermatol200532424324715863844
  • DebruyneFMWitjesFAKetoconazole high dose (HD) in the management of hormonally pretreated patients with progressive metastatic prostate cancerProg Clin Biol Res1987243A3013133659003
  • ConradFPausREstrogens and the hair follicleJ Dtsch Dermatol Ges20042641242316281598
  • YipLZaloumisSIrwinDAssociation analysis of oestrogen receptor beta gene (ESR2) polymorphisms with female pattern hair lossBr J Dermatol201216651131113422014031
  • RobbinsCMirmiraniPMessengerAGWhat women want – quantifying the perception of hair amount: an analysis of hair diameter and density changes with age in caucasian womenBr J Dermatol2012167232433222524482
  • KondoSHozumiYAsoKOrgan culture of human scalp hair follicles: effect of testosterone and oestrogen on hair growthArch Dermatol Res199028274424452078048
  • ConradFOhnemusUBodoESubstantial sex-dependent differences in the response of human scalp hair follicles to estrogen stimulation in vitro advocate gender-tailored management of female versus male pattern baldingJ Investig Dermatol Symp Proc2005103243246
  • MirmiraniPHormonal changes in menopause: do they contribute to a ‘midlife hair crisis’ in women?Br J Dermatol2011165Suppl 371122171679
  • NissimovJElchalalUScalp hair diameter increases during pregnancyClin Exp Dermatol200328552553012950345
  • AdenugaPSummersPBergfeldWHair regrowth in a male patient with extensive androgenetic alopecia on estrogen therapyJ Am Acad Dermatol2012673e121e12322890743
  • GassmuellerJHoffmannRWebsterATopical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studiesBr J Dermatol2008158110911517986309
  • Blume-PeytaviUKunteCKrispAGarcia BartelsNEllwangerUHoffmannRComparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in womenJ Dtsch Dermatol Ges20075539139517451383
  • BlumeyerATostiAMessengerAEuropean Dermatology Forum (EDF)Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in menJ Dtsch Dermatol Ges20119Suppl 6S1S5721980982
  • AoiNInoueKChikanishiT1α, 25-dihydroxyvitamin D3 modulates the hair-inductive capacity of dermal papilla cells: therapeutic potential for hair regenerationStem Cells Transl Med20121861562623197867
  • FinnerAMNutrition and hair: deficiencies and supplementsDermatol Clin201331116717223159185
  • RajputRJControversy: is there a role for adjuvants in the management of male pattern hair loss?J Cutan Aesthet Surg201032828621031065
  • RogersNEAvramMRMedical treatments for male and female pattern hair lossJ Am Acad Dermatol200859454756618793935
  • LimatASuormalaTHunzikerTWaeltiERBraathenLRBaumgartnerRProliferation and differentiation of cultured human follicular keratinocytes are not influenced by biotinArch Dermatol Res1996288131388750932
  • TafurJMillsPJLow-intensity light therapy: exploring the role of redox mechanismsPhotomed Laser Surg200826432332818665762
  • AvramMRRogersNEThe use of low-level light for hair growth: part IJ Cosmet Laser Ther200911211011719466643
  • OronUIlicSDe TaboadaLStreeterJGa-As (808 nm) laser irradiation enhances ATP production in human neuronal cells in culturePhotomed Laser Surg200725318018217603858
  • BernsteinEFHair growth induced by diode laser treatmentDermatol Surg200531558458615962748
  • GargSMessengerAGAlopecia areata: evidence-based treatmentsSemin Cutan Med Surg2009281151819341938
  • Hairmax.com [homepage on the Internet]Boca RatonLexington International LLC2001–2013 Available from: http://www.hairmax.comAccessed April 11, 2013
  • LeavittMCharlesGHeymanEMichaelsDHairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: a randomized, double-blind, sham device-controlled, multicentre trialClin Drug Investig2009295283292
  • SatinoJMarkou M. Hair regrowth and increased hair tensile strength using the HairMax laser comb for low-level laser therapyInternational Journal of Cosmetic Surgery and Aesthetic Dermatology200352113117
  • KimHChoiJWKimJYShinJWLeeSJHuhCHLow-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trialDermatol Surg Epub432013
  • UngerWPUngerRHHair transplanting: an important but often forgotten treatment for female pattern hair lossJ Am Acad Dermatol200349585386014576664
  • AvramMRColeJPGandelmanMRoundtable Consensus Meeting of The 9th Annual Meeting of The International Society of Hair Restoration SurgeryThe potential role of minoxidil in the hair transplantation settingDermatol Surg2002281089490012410672